The confusing case of NRG-1

  title={The confusing case of NRG-1},
  author={Simon D Brandt and Harry R. Sumnall and Fiona Measham and Jon C. Cole},
  journal={BMJ : British Medical Journal},
Since the recent ban on mephedrone,1 2several alternative products have been introduced on internet websites. One of the most prominently discussed second generation products is Energy 1 (NRG-1), also advertised as naphyrone (naphthylpyrovalerone, O-2482), which originated from a group of compounds previously described in the medicinal chemistry … 
5,6‐Methylenedioxy‐2‐aminoindane: from laboratory curiosity to ‘legal high’
An overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs are provided.
Recreational use of 1‐(2‐naphthyl)‐2‐(1‐pyrrolidinyl)‐1‐pentanone hydrochloride (NRG‐1), 6‐(2‐aminopropyl) benzofuran (Benzofury/ 6‐APB) and NRG‐2 with review of available evidence‐based literature
This study aimed to review the available evidence‐based literature on novel psychoactive substances and to inform health care professionals about the risks and benefits of these substances.
The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
The available literature on the sources, availability, and prevalence of the use of mephedrone, a synthetic cathinone that is used as a recreational drug, is summarized.
Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones.
The preparation of brominated precursors carrying the 3,4-methylenedioxyphenyl nucleus revealed extensive α,α-dibromination: the mass spectral and NMR data of these intermediates are also presented and discussed.
Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity
  • D. Wood, P. Dargan
  • Biology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2012
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
A state-of-the-art review on mephedrone history and prevalence of misuse, chemistry, pharmacology, legal status, product market appearance, clinical/management and related fatalities is provided.
Naphyrone: a “legal high” not legal any more
Naphyrone, also known as naphthylpyrovalerone and O-2482, is a cathinone derivative that has been recently advertized for purchase on a number of websites and is likely to share the same risks, such as anxiety, paranoia, and overstimulation of the heart and circulatory system.
Mephedrone, “Bubble” and unidentified white powders : the contested identities of synthetic “legal highs”
Purpose – In this fourth paper in a series on emergent drug trends in the UK (2006 ketamine, 2009 MDMA powder/crystal, 2010 mephedrone), the authors consider how the pharmacological landscape has


1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
This array of 2-aminopentanophenones has yielded selective inhibitors of the dopamine and norepinephrine transporters with little effect upon serotonin trafficking and the most potent of these DAT/NET selective compounds are the 1-naphthyl- (4t) 2-pyrrolidin-1-yl-pentan- 1-one analogues.
Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition
Significant changes in British recreational drug use were seen throughout 2009, with the emergence and rapid growth in the availability and use of substituted cathinones or ‘M‐Cats’ (most notably
What should be done about mephedrone?
The authors should focus on crafting the most effective public health response to climate change, and not worry about how to respond to natural disasters.